Contact Me

Michael Weintraub

Endocrinology • Obesity Medicine
PHYSICIAN | EDUCATOR | RESEARCHER
Dr. Michael A Weintraub is a triple board-certified physician with a specialty focus in obesity medicine.
Dr. Michael A. Weintraub

About Me

Dr. Weintraub's approach emphasizes collaboration and tailored treatment plans, ensuring patients receive the best possible care suited to their unique needs. He specializes in managing patients with a wide range of endocrine conditions, including obesity, diabetes, osteoporosis, and disorders of the thyroid, adrenal, and pituitary disorders.

His particular interest lies in obesity medicine, a dynamic field that offers increasingly effective tools for treating and preventing weight gain, which is often the root cause of many chronic diseases. By working closely with nutritionists, surgeons, and other specialists, he strives to deliver holistic and effective care.

In addition to caring for patients, Dr. Weintraub is passionate about academic medicine, research, and training the next generation of physicians. He co-chairs the pharmacologic management of obesity guideline update through the Endocrine Society and serves on the exam writing committee for the American Board of Obesity Medicine. He is actively involved in clinical research within endocrinology and obesity medicine.

Education and Training

Endocrinology
Fellowship
Cornell New York Presbyterian Hospital, Memorial Sloan Kettering Cancer Center
Internal Medicine
Residency
Thomas Jefferson University Hospital
Medical School Rutgers Robert Wood Johnson Medical School
Undergraduate University of Pennsylvania Roy and Diana Vagelos Life Science and Management Dual Degree Program
Board Certifications
  • Internal Medicine
  • Endocrinology, Diabetes & Metabolism
  • Diplomate of American Board of Obesity Medicine

Educator

Endocrine News Podcast

Dr. Michael Weintraub speaks about compounded obesity medications.

Listen Now

New EASO Framework for treating obesity

Michael A. Weintraub, MD, discusses how the new European Association for the Study of Obesity (EASO) framework reshapes the way clinicians diagnose and treat obesity by moving beyond BMI.

Read More

Research on weight regain after stopping GLP1s

Dr. Weintraub discusses recent real-world data he presented at ObesityWeek on the degree of weight regain after GLP1 discontinuation.

Read More

Publication Title 4

Brief description of this educational content or publication. This could be a journal article, presentation, or educational resource.

Read More

Publication Title 5

Brief description of this educational content or publication. This could be a journal article, presentation, or educational resource.

Read More

Practice Location

NYU Langone Diabetes & Endocrine Associates
222 East 41st Street, 23rd Floor
New York, NY 10017

View on Google Maps

Featured Publications